Table 2 Ratio of mean and median patient interval over mean and median primary care interval, by cancer site
Cancer diagnosis | Mean patient interval/Mean primary care interval | Median patient interval/Median primary care interval |
|---|---|---|
Breast | 5.2 (4.0–6.6) | * (*–*) |
Melanoma | 4.1 (3.0–5.6) | * (*–*) |
Testicular | 4.1 (2.3–7.3) | 8.0 (1.8–*) |
Vulval | 3.6 (1.8–9.0) | 17.0 (3.5–*) |
Cervical | 3.1 (1.8–5.3) | 5.0 (1.3–39.0) |
Endometrial | 2.6 (1.8–3.8) | 14.0 (9.0–*) |
Oropharyngeal | 2.4 (1.5–4.0) | 5.5 (1.8–30.5) |
Laryngeal | 1.9 (1.1–3.8) | 4.9 (2.4–19.3) |
Ovarian | 1.9 (1.4–2.6) | 2.0 (1.1–2.8) |
Thyroid | 1.9 (1.1–4.1) | 2.4 (0.9–5.3) |
Brain | 1.7 (0.9–3.3) | 1.8 (0.8–8.0) |
Mesothelioma | 1.7 (1.0–3.0) | 2.4 (0.7–6.0) |
Small intestine | 1.7 (0.8–3.3) | 1.1 (0.2–4.1) |
Colorectal | 1.6 (1.4–1.8) | 3.2 (2.6–4.5) |
Oesophageal | 1.5 (1.2–1.9) | 4.3 (2.2–11.5) |
Prostate | 1.5 (1.3–1.8) | 0.6 (0.5–0.8) |
Leukaemia | 1.3 (0.8–2.0) | 1.8 (0.6–3.5) |
Lymphoma | 1.2 (0.9–1.5) | 1.6 (1.2–2.4) |
Lung | 1.0 (0.8–1.2) | 0.8 (0.6–1.1) |
Sarcoma | 1.0 (0.5–2.1) | 1.9 (0.4–4.5) |
Stomach | 1.0 (0.7–1.5) | 0.8 (0.3–1.9) |
Liver | 0.9 (0.4–2.0) | 1.3 (0.5–3.3) |
Bladder | 0.8 (0.6–1.2) | 0.7 (0.3–1.5) |
Gallbladder | 0.8 (0.3–2.1) | 0.2 (0.0–0.7) |
Myeloma | 0.8 (0.4–1.3) | 0.7 (0.3–1.0) |
Pancreatic | 0.8 (0.6–1.1) | 1.4 (0.8–2.0) |
Renal | 0.7 (0.5–1.1) | 0.2 (0.1–0.5) |
Unknown primary | 0.7 (0.4–1.3) | 0.5 (0.2–1.3) |
